ClinicalTrials.gov
ClinicalTrials.gov Menu

Identification of Inpatients at Risk for Poor Glycemic Control

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01043042
Recruitment Status : Completed
First Posted : January 6, 2010
Last Update Posted : April 4, 2017
Sponsor:
Information provided by (Responsible Party):
Vanderbilt University Medical Center

Brief Summary:
Both hypoglycemia and hyperglycemia can be detrimental to hospitalized patients. However, it is not clear which patients are more likely to develop significant problems with hypoglycemia or severe hyperglycemia in the hospital. Our hypothesis is that we will be able to identify risk factors present at admission that identify patients at greater risk of poor inpatient glycemic control

Condition or disease Intervention/treatment
Hypoglycemia Hyperglycemia Other: No interventions will be used in this study

Study Type : Observational
Actual Enrollment : 33011 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Identification of Inpatients at Risk for Poor Glycemic Control
Study Start Date : January 2010
Actual Primary Completion Date : September 2014
Actual Study Completion Date : September 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
Hospitalized patients
patients hospitalized at VUH between 4/1/2008 to 10/31/2009
Other: No interventions will be used in this study
No interventions will be used in this study



Primary Outcome Measures :
  1. hypoglycemia or hypoglycemia [ Time Frame: during hospitalization ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Candidates for inclusion will include all adult (age ≥ 18 years) patients admitted to Vanderbilt University Medical Center from 04/01/2008 to 10/31/2009. Patients will be excluded if they were pregnant at the time of admission or had length of stay < 24 hours.
Criteria

Inclusion Criteria:

  • age ≥ 18 years
  • hospitalized in VUH

Exclusion Criteria:

  • -length of stay < 24 hours
  • pregnant women
  • patients receiving palliative/hospice care

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01043042


Locations
United States, Tennessee
Vanderbilt University Hospital
Nashville, Tennessee, United States, 37232
Sponsors and Collaborators
Vanderbilt University Medical Center
Investigators
Principal Investigator: Jeffrey Boord, MD MPH Vanderbilt University

Responsible Party: Vanderbilt University Medical Center
ClinicalTrials.gov Identifier: NCT01043042     History of Changes
Other Study ID Numbers: 091507
First Posted: January 6, 2010    Key Record Dates
Last Update Posted: April 4, 2017
Last Verified: March 2017

Keywords provided by Vanderbilt University Medical Center:
hypoglycemia among inpatients
hyperglycemia among inpatients

Additional relevant MeSH terms:
Hypoglycemia
Hyperglycemia
Glucose Metabolism Disorders
Metabolic Diseases